Q32 Bio (QTTB) Non-Current Debt (2023 - 2026)

Q32 Bio's Non-Current Debt history runs 4 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• On a quarterly basis, Non-Current Debt fell 75.88% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a 75.88% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, down 63.66% from the prior year.
• Non-Current Debt slipped to $1.9 million in Q1 2026 per QTTB's latest filing, from $3.5 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $12.6 million in Q2 2024 and bottomed at $1.9 million in Q1 2026.
• The 4-year median for Non-Current Debt is $7.3 million (2025), against an average of $7.2 million.
• Across the five-year window, Non-Current Debt soared 108.6% in 2024 and tumbled 75.88% in 2026, its largest moves.
• Year by year, Non-Current Debt stood at $4.6 million in 2023, then surged by 108.6% to $9.6 million in 2024, then slumped by 63.66% to $3.5 million in 2025, then sank by 44.17% to $1.9 million in 2026.
• Per Business Quant, the three latest QTTB Non-Current Debt figures stand at $1.9 million (Q1 2026), $3.5 million (Q4 2025), and $5.0 million (Q3 2025).